CD19 and myasthenia gravis: The proportion of CD19+CD24hiCD38hi B cell subset in MG patients was also significantly lower than that in matched healthy controls (p < 0.05), whereas there was no significant difference in the proportion of CD19+CD24hiCD38hi B cell subsets between the GMG and OMG patients (Figures 2A, B).